Also trades as: RP.V (TSXV) · $vol 0M
REPCF OTC
RepliCel Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -98.6%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$531K
+62.5% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$531K
+62.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$57K
+83.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$4M | -$743K | -$312K | -$97K |
| Depreciation & Amort. | $2K | $1K | $839 | $1K | $541 |
| Stock-Based Comp. | $3K | $472K | $69K | $241K | $32K |
| Change in Working Capital | $916K | -$324K | $268K | $120K | $30K |
| Other Non-Cash Items | -$281K | $561K | -$1M | -$1M | -$496K |
| Operating Cash Flow | -$765K | -$3M | -$1M | -$1M | -$531K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $12K | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $17K |
| Investing Cash Flow | $12K | $0 | $0 | $0 | $17K |
| — Financing Activities — | |||||
| Net Debt Issuance | $107K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $3M | $0 | $1M | $456K |
| Financing Cash Flow | $764K | $3M | $2M | $1M | $456K |
| Net Change in Cash | $10K | $187K | $192K | -$354K | -$57K |
| Cash End of Period | $34K | $221K | $413K | $59K | $2K |
| Free Cash Flow | -$765K | -$3M | -$1M | -$1M | -$531K |